Delivery Order SPE2DB22D2206-SPE2DB25FHE25

Award Date 5/29/25
Potential Completion Date 6/20/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPK75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,670.51 firm fixed-price delivery order is for the supply of MEKINIST 2 MG TABLET medication. The contract has an ultimate completion date of February 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,341.02 firm fixed-price delivery order is for the supply of 4,568,131,488 units of the medication MEKINIST 2MG TAB 30S. The contract has an ultimate completion date of May 27, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $18,371.32 fixed-price award is for the delivery of 4,566,462,969 units of the drug MEKINIST 2 MG Tablet with a completion date of December 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the award is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,670.51 firm fixed-price contract is for the delivery of MEKINIST 2 MG TABLET 30S, a prescription medication. The delivery order has a completion date of June 12, 2025 and is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,670.51, is for the delivery of Mekinist 2 mg tablets, a prescription medication. The delivery order has a firm fixed price and an ultimate completion date of May 23, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,160,759 units of the prescription medication MEKINIST 0.5 mg Tablet, with a firm fixed price ceiling value of $11,403.32 and a completion date of May 28, 2025. The contract is not set aside and represents an individual delivery order under a larger Indefinite Delivery...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of the prescription drug Mekinist 0.5 mg tablet, with a ceiling value of $8,552.49 and a period of performance through May 23, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,589.70 for the provision of MEKINIST 0.5 MG TABLET medical products. The award was made on June 6, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 28, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $22,937 firm fixed-price delivery order is for the supply of the prescription medication Mekinist 2 mg tablets. The contract has an ultimate completion date of November 25, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation (Amerisourcebergen), a major pharmaceutical distributor, for the delivery of MEKINIST 0.5 MG TABLET. The contract has a ceiling value of $2,589.70 and an ultimate completion date of August 6, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation. Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies to supply a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FHE25
    Delivery Order

This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of MEKINIST 0.5 mg tablets. The contract, valued at $17,104.98, has a firm fixed price and is funded by the Defense Logistics Agency (DLA), a defense agency. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract does not have a set-aside designation, indicating open competition.

Generated 8/28/25, 9:59 AM